General Fusion Inc.
USPTO PatentsView assignee record - 22 granted patents across 21 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G21B (Fusion Reactors).
The verdict
According to USPTO PatentsView, General ranks #13,440 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 21 technology areas.
- #13,440
- of 49,997 US assignees by volume
- Top 37%
- by Innovation Score (40.0/100)
- 16.9
- avg claims per patent
- -31%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R13440 · Foreign Corporation #13,440 · 22 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
- GRANTS-SMALL 22 grants
- MID-PACK #13,440/49,997
- PHOTO-FINISH Galera Labs
- CPC-FOCUS G21B · 21 areas
- INNOV-PAR 40.0/100
- CLAIMS-RICH 16.9 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DOWN -31% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Galera Labs, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How General’s 40.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around General
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- General Fusion · this assignee
General Fusion · this assignee
40 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows General's Innovation Score is 40.0/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for General?
Each dot is one of General’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). General’s own 16.9 claims/patent is ABOVE the 11.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where General's grants concentrate
General Fusion Inc. is a focused PatentsView assignee: 21 CPC subclasses with 81.8% of grants classified under G21B (Fusion Reactors). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2019. By volume, General sits between Glaxosmithkline Consumer Healthcare (UK) IP Limited and Global Marketing Enterprise (GME) Ltd..
General's three-year grant acceleration
General Fusion Inc. shows 3 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at General's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Glaxosmithkline C…
Glaxosmithkline Consumer Healthcare (UK) IP Limited
22 patents
- GPB Scientific
GPB Scientific, LLC
22 patents
- Gpsip
GPSip, Inc.
22 patents
- Galera Labs
Galera Labs, LLC
22 patents
- Genesis Advanced…
Genesis Advanced Technology Inc.
22 patents
- Genesis Robotics…
Genesis Robotics and Motion Technologies Canada, ULC
22 patents
- Gestamp Hardtech…
Gestamp Hardtech AB
22 patents
- Global Marketing…
Global Marketing Enterprise (GME) Ltd.
22 patents
- General Fusion ◀
General Fusion Inc.
22 patents
What this shows General holds 22 patents at rank #13,443, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near General
By rank, the assignees closest to #13,443 in granted patent volume.
- Glaxosmithkline Consumer Healthcare (UK) IP Limited #13,439 · 22 patents
- GPB Scientific, LLC #13,440 · 22 patents
- GPSip, Inc. #13,441 · 22 patents
- Galera Labs, LLC #13,442 · 22 patents
- Genesis Advanced Technology Inc. #13,444 · 22 patents
- Genesis Robotics and Motion Technologies Canada, ULC #13,445 · 22 patents
- Gestamp Hardtech AB #13,446 · 22 patents
- Global Marketing Enterprise (GME) Ltd. #13,447 · 22 patents
Leaders in G21B (Fusion Reactors)
Other assignees with the most granted patents in General's primary technology class.
- Tokamak Energy Ltd 30 in class
- TAE Technologies, Inc. 29 in class
- Innoven Energy, LLC 11 in class
- Hefei Institutes of Physical Sciences, Chinese Academy of Sciences 8 in class
- Brilliant Light Power, Inc. 8 in class
- Alpha Ring International Limited 8 in class
- Zap Energy, Inc. 6 in class
- Advanced Fusion Systems LLC 5 in class
General's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 37% higher than 63% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 5 | 22.7% |
| 2017 | 2 | 9.1% |
| 2018 | 5 | 22.7% |
| 2019 | 1 | 4.5% |
| 2020 | 3 | 13.6% |
| 2021 | 3 | 13.6% |
| 2022 | 2 | 9.1% |
| 2023 | 1 | 4.5% |
Which technologies does General Fusion Inc. patent most?
Top 15 of 21 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
General Fusion Inc.'s patent record in context - here's where to go next.
- General Fusion Inc.'s lead technology class is G21B (Fusion Reactors), 81.8% of its portfolio - see every assignee active in that class. Explore G21B
- Ranked #13,440 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare General Fusion Inc. against Glaxosmithkline Consumer Healthcare (UK) IP Limited, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 40.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.